Skip to main content
. 2023 May 22:1–140. Online ahead of print. doi: 10.1007/s00464-023-10071-4
Variable No haloperidol Haloperidol p-value
Male 6.4% 9.1%  > 0.999
Female 93.6% 90.9%  > 0.999
Average Age (years) 42.5 42.2 0.944
Average BMI 42.98 43.49 0.406
Complication Rate 11.3% 3.6% 0.13
Reported Episodes of PONV 50.45% 15.0% 0.03
Need for ≥ 3 doses of Ondansetron 50.57% 26.79% 0.004
Need for Rescue Antiemetic 35.71% 19.64% 0.02
Length of Stay (hours) 40.33 22.66  < 0.0001